These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 19581812)
1. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers. Friedrich-Rust M; Müller C; Winckler A; Kriener S; Herrmann E; Holtmeier J; Poynard T; Vogl TJ; Zeuzem S; Hammerstingl R; Sarrazin C J Clin Gastroenterol; 2010 Jan; 44(1):58-65. PubMed ID: 19581812 [TBL] [Abstract][Full Text] [Related]
2. [Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis]. Van Beers B Bull Mem Acad R Med Belg; 2009; 164(1-2):44-50; discussion 51-2. PubMed ID: 19718953 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083 [TBL] [Abstract][Full Text] [Related]
15. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740 [TBL] [Abstract][Full Text] [Related]
17. Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients. Kamphues C; Lotz K; Röcken C; Berg T; Eurich D; Pratschke J; Neuhaus P; Neumann UP Clin Transplant; 2010; 24(5):652-9. PubMed ID: 19925459 [TBL] [Abstract][Full Text] [Related]
18. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Corpechot C; El Naggar A; Poujol-Robert A; Ziol M; Wendum D; Chazouillères O; de Lédinghen V; Dhumeaux D; Marcellin P; Beaugrand M; Poupon R Hepatology; 2006 May; 43(5):1118-24. PubMed ID: 16628644 [TBL] [Abstract][Full Text] [Related]
19. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C. Sasso M; Tengher-Barna I; Ziol M; Miette V; Fournier C; Sandrin L; Poupon R; Cardoso AC; Marcellin P; Douvin C; de Ledinghen V; Trinchet JC; Beaugrand M J Viral Hepat; 2012 Apr; 19(4):244-53. PubMed ID: 22404722 [TBL] [Abstract][Full Text] [Related]
20. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Castera L J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]